» Articles » PMID: 10075959

Linkage of Crohn's Disease to the Major Histocompatibility Complex Region is Detected by Multiple Non-parametric Analyses

Overview
Journal Gut
Specialty Gastroenterology
Date 1999 Mar 17
PMID 10075959
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is evidence for genetic susceptibility to Crohn's disease, and a tentative association with tumour necrosis factor (TNF) and HLA class II alleles.

Aims: To examine the potential of genetic linkage between Crohn's disease and the MHC region on chromosome 6p.

Methods: TNF microsatellite markers and, for some families, additional HLA antigens were typed for 323 individuals from 49 Crohn's disease multiplex families to generate informative haplotypes. Non-parametric linkage analysis methods, including sib pair and affected relative pair methods, were used.

Results: Increased sharing of haplotypes was observed in affected sib pairs: 92% (48/52) shared one or two haplotypes versus an expected 75% if linkage did not exist (p=0.004). After other affected relative pairs were included, the significance level reached 0.001. The mean proportion of haplotype sharing was increased for both concordant affected (pi=0.60, p=0.002) and unaffected sib pairs (pi=0.58, p=0. 031) compared with the expected value (pi=0.5). In contrast, sharing in discordant sib pairs was significantly decreased (pi=0.42, p=0. 007). Linear regression analysis using all three types of sib pairs yielded a slope of -0.38 at p=0.00003. It seemed that the HLA effect was stronger in non-Jewish families than in Jewish families.

Conclusions: All available analytical methods support linkage of Crohn's disease to the MHC region in these Crohn's disease families. This region is estimated to contribute approximately 10-33% of the total genetic risk to Crohn's disease.

Citing Articles

The association between psoriasis, psoriasis severity, and inflammatory bowel disease: a population-based analysis.

Shani U, Ben-Shabat N, Qassem R, Lahat A, Omar M, Savin E Therap Adv Gastroenterol. 2024; 17:17562848241227037.

PMID: 38282955 PMC: 10822082. DOI: 10.1177/17562848241227037.


Therapeutic drug monitoring for biological medications in inflammatory bowel disease.

Cogan R, El-Matary B, El-Matary W Saudi J Gastroenterol. 2022; 28(5):322-331.

PMID: 35343213 PMC: 9752529. DOI: 10.4103/sjg.sjg_3_22.


Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Sheu T, Chiang B Int J Mol Sci. 2021; 22(8).

PMID: 33923792 PMC: 8073364. DOI: 10.3390/ijms22084152.


Association of Clinical Features with Human Leukocyte Antigen in Japanese Patients with Ulcerative Colitis.

Iwamoto T, Yashima K, Morio K, Ueda N, Ikebuchi Y, Kawaguchi K Yonago Acta Med. 2018; 61(1):27-32.

PMID: 29599619 PMC: 5871723.


Psoriasis and inflammatory bowel disease: links and risks.

Vlachos C, Gaitanis G, Katsanos K, Christodoulou D, Tsianos E, Bassukas I Psoriasis (Auckl). 2018; 6:73-92.

PMID: 29387596 PMC: 5683131. DOI: 10.2147/PTT.S85194.


References
1.
Forcione D, Sands B, Isselbacher K, Rustgi A, Podolsky D, Pillai S . An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci U S A. 1996; 93(10):5094-8. PMC: 39412. DOI: 10.1073/pnas.93.10.5094. View

2.
Cervero F . Visceral pain: mechanisms of peripheral and central sensitization. Ann Med. 1995; 27(2):235-9. DOI: 10.3109/07853899509031965. View

3.
Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A . HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology. 1995; 109(5):1462-7. DOI: 10.1016/0016-5085(95)90631-2. View

4.
Hermiston M, Gordon J . Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 1995; 270(5239):1203-7. DOI: 10.1126/science.270.5239.1203. View

5.
Chauhan A, Petch M, Schofield P . Effect of oesophageal acid instillation on coronary blood flow. Lancet. 1993; 341(8856):1309-10. DOI: 10.1016/0140-6736(93)90817-z. View